Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03803878
Other study ID # 2018-162-KY
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2019
Est. completion date December 30, 2022

Study information

Verified date September 2020
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact Zhishun Liu, PhD
Phone 86-010-88002331
Email zhishunjournal@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study is to translate the Medical, Epidemiologic, and Social aspects of Aging (MESA) urinary incontinence questionnaire into a Chinese language version and test the reliability and validity among women with urgency-predominant mixed urinary incontinence.

The hypothesis is that the Chinese language version of the MESA questionnaire will have adequate measurement properties (e.g. reliability and validity).


Description:

Mixed urinary incontinence(MUI) is regarded as urgency-predominant when urgency incontinence episodes dominate over stress incontinence episodes, and vice versa. The treatment of MUI often begins with the most bothersome symptoms.

MESA questionnaire is a reliable and validated tool to evaluate the severity and predominance of stress or urgency urinary incontinence. At present, it hasn't been translated into a Chinese language version and validated.

The validation study of MESA questionnaire is embedded in a randomized controlled trial conducted among female patients, of which the data will be collected and analysed.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date December 30, 2022
Est. primary completion date August 30, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion criteria

1. Female patients diagnosed with MUI in accordance with EAU guideline by history taking, physical examination, laboratory tests and specialist diagnosis;

2. Age between 18 and 80 years old;

3. At least 4 episodes of UUI in 3-day voiding diary;

4. With MUI for at least 3 months, and urgency urinary incontinence dominates more than 50% of the total incontinence episodes in 3-day voiding diary;

5. Positive cough test;

6. A voluntarily-signed written informed content. For patients in group 1, inclusion criteria of 1), 2), 5) and 6) are required to meet. Those also meeting the criteria of 3) and 4) will enter group 2 at the same time.

For patients in group 2 and groups 3, all inclusion criteria are required to meet.

Exclusion criteria

1. Having pure SUI, pure UUI, overflow UI or neurogenic bladder;

2. Uncontrolled urinary tract infection;

3. Tumor in urinary system or pelvic organs;

4. Pelvic organ prolapse=degree?;

5. Residual urine volume=100ml;

6. Maximum flow rate<15ml/s;

7. In the past 1 month, receiving treatment of acupuncture or positive medications targeted at incontinence, such as antimuscarinic drugs;

8. Underwent anti-incontinence or pelvic organ surgery, including metrectomy;

9. Complication of severe diabetes or hypertension;

10. Complication of diseases in nervous system that could hamper hypourethral function, such as multiple sclerosis, senile dementia, Parkinson's disease, spinal cord injury, cauda equina nerve injury and multiple system atrophy;

11. Severe complications in cardiac, lungs, cerebrum, hepar, renal system, psychonosology and coagulation function, or obvious cognitive disability;

12. Installed a cardiac pacemaker;

13. Allergic to Solifenacin or with contraindications to antimuscarinic drug, including urinary retention, gastrointestinal peristalsis paralysis, myasthenia gravis, ulcerative colitis and angle-closure glaucoma;

14. Allergic to metal or intolerant to the stimulation of electroacupuncture;

15. Pregnant or plan to conceive in the future 1 year, or delivery in the past one year.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Guang An Men Hospital Beijing

Sponsors (1)

Lead Sponsor Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The criteria validity of MESA questionnaire compared with extended clinical evaluation in deciding predominant components of MUI. The extended clinical evaluation mainly includes physical examination, 3-day voiding diary, cough stress teat, urinalysis and residual urine volume by ultrasonography. screening and baseline periods
Secondary The criteria validity of MESA questionnaire compared with International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) in severity assessing among women with urgency-predominant mixed urinary incontinence. ICIQ SF is a validated questionnaire to evaluate both the severity of incontinence symptoms and influence on QoL in the past four weeks. The questionnaire is consisted of four items, including frequency, leakage amount, impact on QoL and the cause of urinary incontinence. The total score of the ICIQ SF ranges from 0 to 21, with a higher score indicating worse symptoms and QoL. baseline
Secondary The criteria validity of MESA questionnaire compared with 3-day voiding diary in severity assessing among women with urgency-predominant mixed urinary incontinence. In 3-day voiding diary, the type and episodes of incontinence are all recorded. baseline
Secondary The test-retest reliability of MESA questionnaire The test-retest reliability of MESA will be evaluated at the screening and baseline period with about one- to two-week interval among women with urgency-predominant mixed urinary incontinence. screening and baseline periods
Secondary The responsiveness of MESA questionnaire The responsiveness of MESA questionnaire will be evaluated before and after the treatment among women with urgency-predominant mixed urinary incontinence compared with 3-day voiding diary and ICIQ SF. baseline, week 12
See also
  Status Clinical Trial Phase
Completed NCT05514587 - Meaning of Life Questionnaire (MLQ) in Patients Admitted to the Crisis Centre (MSVCAC)
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Recruiting NCT06293001 - Cross-Cultural Adaptation, Validity and Reliability of the Turkish Version of the ADAP Shoulder Scale
Completed NCT05416528 - Chinese Translation and Validation of the 8-item Contact Lens Dry Eye Questionnaire (CLDEQ-8)
Not yet recruiting NCT03477240 - Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients
Not yet recruiting NCT03074747 - Comparison of Four Questionnaires for OSA Screening in China N/A
Recruiting NCT04492085 - National Survey of Workplace Violence
Recruiting NCT04491201 - National Survey of the Impact of COVID-19 Pandemics
Recruiting NCT06266273 - Investigating the Development, Validity, and Reliability of the Avoidance of Sports Activities Photo Scale N/A
Completed NCT04406025 - Regional Anesthesia Practice in Greece
Recruiting NCT05213416 - BETY-BIOPSYCHOSOCIAL QUESTIONNAIRE IN PARTİCİPANTS RECEIVING RADIOTHERAPY
Completed NCT01277588 - Evaluation of the Physicians and Patients Experience of Fetal Scalp Sampling N/A
Completed NCT03164824 - Thai Version of Functional Rating Index N/A
Active, not recruiting NCT05903300 - Validation of the Polish Version of the MPIIQM Questionnaire for Musicians
Recruiting NCT04785040 - The Turkish Version of the Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians (MPIIQM-T)
Recruiting NCT06075186 - Secondary Victim Awareness of Anesthesiologists